This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Floyd E. Bloom, MD

Arch Gen Psychiatry. 1993;50(3):224-227.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A long-standing view has been that the study of the schizophrenic brain was the graveyard of neuropathologists.¹ Not too many years ago, inconsistencies in postmortem reports of cellular neuropathology in schizophrenics led some to conclude that such efforts were premature. Both views have since been displaced by an avalanche of consistent structural and functional evidence of microscopic pathology in the frontal and temporal lobes of schizophrenics.^2-11 Moreover, the morphologic validation of schizophrenic neuropathology has accelerated in the past decade with noninvasive methods to assess brain structure and function, establishing enlarged ventricles, reduced cortical gray matter, and hypometabolism of the frontal lobes and elements of the basal ganglia. Numerous examples have recently appeared in the ARCHIVES.^12-19

The wealth of evidence attesting to a substantial neuropathology in schizophrenia leaves few doubters. Rather, the focus has turned to the issue of which changes are reproducible signs of the pathology and . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Neuropharmacology, The Scripps Research Institute, La Jolla, Calif.

Footnotes
Accepted for publication January 20, 1993.

Reprint requests to the Department of Neuropharmacology, The Scripps Research Institute, 10666 N Torrey Pines Rd, La Jolla, CA 92037 (Dr Bloom).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?